Get started
Work

Supplementary Figure 1 from Prognostic Biomarkers in Phase II Trial of Cetuximab-Containing Induction and Chemoradiation in Resectable HNSCC: Eastern Cooperative Oncology Group E2303

Year: 2023
Type: supplementary-materials
Abstract: PDF file - 65K, REMARK Flow Chart of E2303 translational research study.
DOI: 10.1158/1078-0432.22455230
Authors: Amanda Psyrri, Ju-Whei Lee, Eirini Pectasides, Maria Vassilakopoulou, Efstratios K. Kosmidis, Barbara A. Burtness, David L. Rimm, Harold J. Wanebo, Arlene A. Forastiere
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361883884
Cites:
Cited by: 1
Related to: 10